Literature DB >> 9384199

Study designs for evaluating different efficacy and effectiveness aspects of vaccines.

M E Halloran1, C J Struchiner, I M Longini.   

Abstract

Vaccine efficacy and effectiveness (VE) are generally measured as 1 minus some measure of relative risk (RR) in the vaccinated group compared with the unvaccinated group (VE = 1 - RR). In designing a study to evaluate vaccination, the type of effect and the question of interest determine the appropriate choice of comparison population and parameter. Possible questions of interest include that of the biologic effect of vaccination on susceptibility, on infectiousness, or on progression to disease in individuals. The indirect effects, total effects, and overall public health benefits of widespread vaccination of individuals within the context of a vaccination program might also be of primary concern. The change in behavior induced by belief in the protective effects of vaccination might influence the estimates of these effects or might itself be of interest. In this paper, the authors present a framework of study designs that relates the scientific question of interest to the choice of comparison groups, the unit of observation, the level of information available for analysis, and the parameter of effect.

Mesh:

Substances:

Year:  1997        PMID: 9384199     DOI: 10.1093/oxfordjournals.aje.a009196

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  87 in total

1.  Design and Evaluation of Prophylactic Interventions Using Infectious Disease Incidence Data from Close Contact Groups.

Authors:  Yang Yang; Ira M Longini; M Elizabeth Halloran
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2006-05       Impact factor: 1.864

2.  Modelling heterogeneity and the impact of chemotherapy and vaccination against human hookworm.

Authors:  L Sabatelli; A C Ghani; L C Rodrigues; P J Hotez; S Brooker
Journal:  J R Soc Interface       Date:  2008-11-06       Impact factor: 4.118

3.  Causal Vaccine Effects on Binary Postinfection Outcomes.

Authors:  Michael G Hudgens; M Elizabeth Halloran
Journal:  J Am Stat Assoc       Date:  2006-03       Impact factor: 5.033

4.  A Data-Augmentation Method for Infectious Disease Incidence Data from Close Contact Groups.

Authors:  Yang Yang; Ira M Longini; M Elizabeth Halloran
Journal:  Comput Stat Data Anal       Date:  2007-08-15       Impact factor: 1.681

5.  Invited commentary: Evaluating vaccination programs using genetic sequence data.

Authors:  M Elizabeth Halloran; Edward C Holmes
Journal:  Am J Epidemiol       Date:  2009-11-12       Impact factor: 4.897

6.  Finite-sample corrected generalized estimating equation of population average treatment effects in stepped wedge cluster randomized trials.

Authors:  JoAnna M Scott; Allan deCamp; Michal Juraska; Michael P Fay; Peter B Gilbert
Journal:  Stat Methods Med Res       Date:  2014-09-29       Impact factor: 3.021

7.  Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacy.

Authors:  M Juraska; P B Gilbert
Journal:  Biometrics       Date:  2013-02-19       Impact factor: 2.571

8.  One versus two doses: What is the best use of vaccine in an influenza pandemic?

Authors:  Laura Matrajt; Tom Britton; M Elizabeth Halloran; Ira M Longini
Journal:  Epidemics       Date:  2015-06-22       Impact factor: 4.396

9.  Antimicrobial use and antimicrobial resistance: a population perspective.

Authors:  Marc Lipsitch; Matthew H Samore
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

10.  Optimizing vaccine allocation at different points in time during an epidemic.

Authors:  Laura Matrajt; Ira M Longini
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.